RAPIFEN
As listed in the register: RAPIFEN 1 mg (0,5 mg/ml), solution injectable
0,544 mg · solution injectable
- Prescription only
- Active substance
- Alfentanil (Chlorhydrate D')
- Made by
- PIRAMAL CRITICAL CARE (PAYS-BAS)
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Details
| Made by | PIRAMAL CRITICAL CARE (PAYS-BAS) |
|---|---|
| Active substance | Alfentanil (Chlorhydrate D') |
| Strength | 0,544 mg |
| Form | solution injectable |
| Route | intraveineuse |
| Dispensing (as stated by the register) | réservé à l'usage HOSPITALIER · réservé à l'usage en situation d'urgence selon l'article R5121-96 du code de la santé publique · prescription limitée à 7 jours · stupéfiants · réservé à une structure d'assistance médicale mobile ou de rapatriement sanitaire · administration par tout médecin spécialiste en ANESTHESIE-REANIMATION ou en MEDECINE D'URGENCE · prescription sur ordonnance sécurisée |
| Marketed | Yes, according to the register |
| Authorisation procedure | Procédure nationale |
| Name in the register | RAPIFEN 1 mg (0,5 mg/ml), solution injectable |
| Packs | 5 ampoule(s) en verre de 2 ml |
| CIS | 68622560 |
| CIP13 | 3400955460572 |
Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician
Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).
Other strengths and forms
2 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- solution injectable2 products
- 0,544 mg
- 5,44 mg
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.